Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Radiofrequency Ablation Simplifies Heart Surgery

By HospiMedica staff writers
Posted on 03 Nov 2006
A new study recommends that radiofrequency (RF) ablation technology be used for the surgical treatment of atrial fibrillation (AF), modifying the Cox-Maze procedure, the current gold standard of AF care.

Researchers from the Washington University School of Medicine and Barnes-Jewish Hospital (St. More...
Louis, MO, USA) conducted a retrospective review of patients with AF who underwent a Cox-Maze procedure, utilizing bipolar radiofrequency ablation, a limited Cox-Maze procedure, or pulmonary vein isolation alone. Follow-up was available on 129 of 130 patients.

The RF device used for the ablation delivered high-energy radiofrequency waves to heart tissue, forming precisely placed scars, or ablations. The ablations disrupt the atria's abnormal electrical activity, placing roadblocks in the way of these misplaced electrical impulses, redirecting them down their normal route so that they stimulate regular heartbeats. The research team found that surgeons needed to apply the devices for only a few seconds at a time to get effective ablation of the atrial wall, and the devices caused no injury to surrounding tissue. The time needed for the procedure was reduced from more than 90 minutes to about 30 minutes.

At the last follow-up, freedom from AF was 90% in the Cox-Maze procedure group, 86% in the limited Cox-Maze procedure group, and 59% in pulmonary-vein isolation-alone group. About three-quarters of the treated patients no longer need drugs to prevent abnormal heart rhythms or excessive blood clotting. The researchers concluded that the use of bipolar RF ablation to replace Cox-Maze incisions was safe and effective at controlling AF. The researchers also found that pulmonary-vein isolation alone was much less effective, and recommended that it be used cautiously in this population. The results were published in the October 2006 edition of Annals of Surgery.

"Because of the devices, the Cox-Maze procedure has gone from an operation that hardly anyone was doing to one that 80- 90% of U.S. heart surgeons are now performing,” said lead author Ralph J. Damiano Jr., M.D., chief of cardiac surgery at the Washington University School of Medicine and a cardiac surgeon at Barnes-Jewish Hospital.

The Cox-Maze procedure is named after James Cox, M.D., former director of Washington University's division of cardiothoracic surgery, who led the research group that developed the procedure in 1987. The original Cox-Maze procedure calls for 10 precisely placed incisions in the upper chambers of the heart that are then sewn up and eventually form scars in the atrial tissue. Using RF ablation replaced all but two of the complex incisions required by the original procedure.



Related Links:
Washington University School of Medicine and Barnes-Jewish Hospital

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.